Literature DB >> 29243036

Mediators of angiogenesis and fibrosis in IgG4-related disease.

Ilaria Puxeddu1, Riccardo Capecchi1, Federico Pratesi1, Silvana Cianchetti2, Antonio Tavoni1, Paola Migliorini3.   

Abstract

IgG4-related disease (IgG4-RD) is a rare fibro-inflammatory condition that can affect almost any organ, characterized by tumefactive lesions and often by eosinophilia and elevated serum IgG4 concentrations. The aim of the study is to analyze in IgG4-RD patients the serum levels of a group of cytokines and growth factors potentially involved in the regulation of fibrotic processes. In the sera of 12 patients affected by IgG4-RD and of 15 normal healthy subjects (NHS), pro-fibrogenic mediators (TGF-β1 and periostin) and pro- (VEGF and angiogenin-1) and anti- (endostatin and thrombospondin-1) angiogenic mediators were measured by sandwich enzyme immunoassay. Among mediators regulating fibrosis and angiogenesis, endostatin levels were significantly higher in IgG4-RD patients compared to NHS (p < 0.0001). No differences in the levels of TGF-β1, periostin, VEGF, angiogenin-1 and thrombospondin-1 were observed between groups. Our study suggests that among the mediators mainly involved in fibrosis and angiogenesis endostatin might play a role in the pathogenetic processes of IgG4-RD.

Entities:  

Keywords:  Angiogenesis; Fibrosis; IgG4-related disease

Mesh:

Substances:

Year:  2017        PMID: 29243036     DOI: 10.1007/s10238-017-0484-z

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  24 in total

Review 1.  Myofibroblasts and mechano-regulation of connective tissue remodelling.

Authors:  James J Tomasek; Giulio Gabbiani; Boris Hinz; Christine Chaponnier; Robert A Brown
Journal:  Nat Rev Mol Cell Biol       Date:  2002-05       Impact factor: 94.444

Review 2.  Consensus statement on the pathology of IgG4-related disease.

Authors:  Vikram Deshpande; Yoh Zen; John Kc Chan; Eunhee E Yi; Yasuharu Sato; Tadashi Yoshino; Günter Klöppel; J Godfrey Heathcote; Arezou Khosroshahi; Judith A Ferry; Rob C Aalberse; Donald B Bloch; William R Brugge; Adrian C Bateman; Mollie N Carruthers; Suresh T Chari; Wah Cheuk; Lynn D Cornell; Carlos Fernandez-Del Castillo; David G Forcione; Daniel L Hamilos; Terumi Kamisawa; Satomi Kasashima; Shigeyuki Kawa; Mitsuhiro Kawano; Gregory Y Lauwers; Yasufumi Masaki; Yasuni Nakanuma; Kenji Notohara; Kazuichi Okazaki; Ji Kon Ryu; Takako Saeki; Dushyant V Sahani; Thomas C Smyrk; James R Stone; Masayuki Takahira; George J Webster; Motohisa Yamamoto; Giuseppe Zamboni; Hisanori Umehara; John H Stone
Journal:  Mod Pathol       Date:  2012-05-18       Impact factor: 7.842

3.  Lesional CD4+ IFN-γ+ cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis.

Authors:  Takashi Maehara; Hamid Mattoo; Miho Ohta; Vinay S Mahajan; Masafumi Moriyama; Masaki Yamauchi; Jefte Drijvers; Seiji Nakamura; John H Stone; Shiv S Pillai
Journal:  Ann Rheum Dis       Date:  2016-06-29       Impact factor: 19.103

4.  B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease.

Authors:  Emanuel Della-Torre; Eoin Feeney; Vikram Deshpande; Hamid Mattoo; Vinay Mahajan; Maria Kulikova; Zachary S Wallace; Mollie Carruthers; Raymond T Chung; Shiv Pillai; John H Stone
Journal:  Ann Rheum Dis       Date:  2014-08-20       Impact factor: 19.103

Review 5.  Angiopoietins in angiogenesis and beyond.

Authors:  Stelios Tsigkos; Micheal Koutsilieris; Andreas Papapetropoulos
Journal:  Expert Opin Investig Drugs       Date:  2003-06       Impact factor: 6.206

Review 6.  Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications.

Authors:  Napoleone Ferrara
Journal:  Semin Oncol       Date:  2002-12       Impact factor: 4.929

7.  Development of an IgG4-RD Responder Index.

Authors:  Mollie N Carruthers; John H Stone; Vikram Deshpande; Arezou Khosroshahi
Journal:  Int J Rheumatol       Date:  2012-04-24

8.  The usefulness of monomeric periostin as a biomarker for idiopathic pulmonary fibrosis.

Authors:  Shoichiro Ohta; Masaki Okamoto; Kiminori Fujimoto; Noriho Sakamoto; Koichiro Takahashi; Hiroshi Yamamoto; Hisako Kushima; Hiroshi Ishii; Keiichi Akasaka; Junya Ono; Ayami Kamei; Yoshinori Azuma; Hisako Matsumoto; Yukie Yamaguchi; Michiko Aihara; Takeshi Johkoh; Atsushi Kawaguchi; Masao Ichiki; Hironori Sagara; Jun-Ichi Kadota; Masayuki Hanaoka; Shin-Ichiro Hayashi; Shigeru Kohno; Tomoaki Hoshino; Kenji Izuhara
Journal:  PLoS One       Date:  2017-03-29       Impact factor: 3.240

9.  Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease.

Authors:  Wei Lin; Panpan Zhang; Hua Chen; Yu Chen; Hongxian Yang; Wenjie Zheng; Xuan Zhang; Fengxiao Zhang; Wen Zhang; Peter E Lipsky
Journal:  Arthritis Res Ther       Date:  2017-02-10       Impact factor: 5.156

10.  Immunoglobulin G4(+) B-cell receptor clones distinguish immunoglobulin G 4-related disease from primary sclerosing cholangitis and biliary/pancreatic malignancies.

Authors:  Marieke E Doorenspleet; Lowiek M Hubers; Emma L Culver; Lucas J Maillette de Buy Wenniger; Paul L Klarenbeek; Roger W Chapman; Frank Baas; Stan F van de Graaf; Joanne Verheij; Thomas M van Gulik; Eleanor Barnes; Ulrich Beuers; Niek de Vries
Journal:  Hepatology       Date:  2016-06-08       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.